Search alternatives:
step decrease » sizes decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
parp decrease » a decrease (Expand Search), pa decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
step decrease » sizes decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
parp decrease » a decrease (Expand Search), pa decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1
Inotodiol decreases clone formation in HCC cells.
Published 2025“…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”
-
2
-
3
-
4
-
5
Overview of the WeARTolerance program.
Published 2024“…This research evaluates the "WeARTolerance’’ arts-based program in reducing mental health stigma among diverse youths. …”
-
6
Application of WeChat-based cognitive behavioural stress management for early-stage cervical cancer patients: a randomised controlled study
Published 2024“…<p>This randomised controlled study was aimed at investigating the effects of WeChat-based cognitive behavioural stress management (WB-CBSM) on the mental health of patients with early-stage cervical cancer treated with surgical resection.…”
-
7
-
8
-
9
-
10
-
11
-
12
PARP9 knockdown promotes apoptosis and DNA damage.
Published 2024“…(E) DNA damage in GC cells significantly increased post-PARP9 knockdown as determined by comet assay. (F) The anti-DNA damage capacity of GC cells decreased markedly following reduction of PARP9 expression. …”
-
13
-
14
-
15
-
16
Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf
Published 2025“…Background<p>High-grade serous carcinoma is a highly metastatic disease with a limited longterm disease control from systemic anti-cancer treatment, for which the radiological treatment response assessment metrics are imprecise. In this work, we developed noninvasive imagingbased measurements of spatial and longitudinal heterogeneity in a retrospective analysis of a phase 2 non-randomized study of germline BRCA1/BRCA2 mutated (gBRCAm) ovarian cancer patients treated with combination of PARP inhibitors (PARPi) and immune checkpoint inhibitors (ICIs).…”
-
17
-
18
-
19
-
20